Mini Review
Accepted on 17 Feb 2025
Could antidepressants increase mood and immunity at the same time? Authors
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1340179
Type at least 3 characters
543 articles
Articles
Editorial
Published on 13 Feb 2025
Editorial: Case reports in psychopharmacology, volume II
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1554037
- 161 views
Original Research
Accepted on 12 Feb 2025
Long-term effectiveness, adherence and safety of twice-yearly paliperidonepalmitate long acting-injectable in patients with schizophrenia in Europe: 2-year mirror-image data from the Paliperdone-2 per Year study (P2Y)
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1540213
Brief Research Report
Accepted on 10 Feb 2025
Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreening
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1450111
Original Research
Published on 05 Feb 2025
Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1506142
- 298 views
Case Report
Published on 03 Feb 2025
Treatment of neuropathic pain with repeated low-dose MDMA: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1513022
- 1,145 views
Case Report
Accepted on 27 Jan 2025
Acute myasthenia caused by lithium: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1467267
Perspective
Published on 23 Jan 2025
Bringing MDMA-assisted therapy for PTSD to traditional healthcare systems: tending to set and setting
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1433999
- 846 views
Review
Published on 10 Jan 2025
A systematic review and meta-analysis of the effects of combined aripiprazole on glycolipid metabolism in schizophrenia
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1496986
- 527 views
Correction
Published on 23 Dec 2024
Corrigendum: Physical disability and psychedelic therapies: an agenda for inclusive research and practice
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1523364
- 305 views
Original Research
Published on 20 Dec 2024
Clinical pharmacist recommendations in daily interdisciplinary ward rounds at a psychiatric hospital: a retrospective pre-post study on drug-related problems focused in somatic comorbidities
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1473832
- 520 views
Original Research
Published on 09 Dec 2024
Association between polypharmacy and the long-term prescription of hypnotics in Japan: a retrospective cross-sectional study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1471457
- 700 views
Systematic Review
Published on 09 Dec 2024
Phytochemicals in the treatment of patients with depression: a systemic review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1509109
- 1,215 views
Case Report
Published on 04 Dec 2024
Pregabalin treatment in a 30-year-old patient with Bainbridge-Ropers syndrome: a case-report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1502773
- 1,219 views
Systematic Review
Published on 04 Dec 2024
Prevalence and solving strategies of drug-related problems in adult psychiatric inpatients - a systematic review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1460098
- 606 views
Opinion
Published on 12 Nov 2024
Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1491417
- 2,102 views